Nontaphat Leerach

Nontaphat Leerach

Auto-generated profile, based on publicly available information

Nontaphat Leerach

Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in Glycoconjugate Journal
Verified
Journal Article
Closed access
PDF file
NLNontaphat Leerach
Nontaphat Leerach
AHAi Harashima
Ai Harashima
SMSeiichi Munesue
Seiichi Munesue
KKKumi Kimura
Kumi Kimura
YOYu Oshima
Yu Oshima
Yasuhiko YamamotoYasuhiko Yamamoto
Yasuhiko Yamamoto

1 September 2024 in Translational Pediatrics
Verified
Journal Article
Open access
PDF file
NLNontaphat Leerach
Nontaphat Leerach
SSSutthirat Sitthisak
Sutthirat Sitthisak
TKThawatchai Kitti
Thawatchai Kitti
NTNattawat Teerawattanapong
Nattawat Teerawattanapong
WMWiriya Mahikul
Wiriya Mahikul
KTKannipa Tasanapak
Kannipa Tasanapak
Background: Mycoplasma pneumoniae (M. pneumoniae) is a common pathogen of community-acquired pneumonia. Interleukin-17 (IL-17) plays a role in host defense and contributes to disease severity in infection. This present study aims to investigate the association between Mycoplasma pneumoniae pneumonia (MPP) and changes of IL-17 level in the serum of pediatric patients. Methods: The protocol has been registered in PROSPERO (CRD42023489451). A literature search was conducted in PubMed, EMBASE, Scopus, and Web of Science from inception to October 2023. A meta-analysis was performed to pool the mean difference (MD) with 95% confidence intervals (CIs) of IL-17 levels between patients and controls. Publication bias was assessed, and the risk of bias was evaluated using the Newcastle-Ottawa Scale (NOS). Results: Out of 207 records, 10 studies were included in the review and 9 studies were included in the meta-analysis. Of these, 7 studies compared IL-17 in general MPP patients with controls, 6 studies compared severe MPP patients with mild MPP patients. Serum IL-17 levels were significantly elevated in general MPP patients compared with control (MD =33.94 pg/mL, 95% CI: 24.66, 43.22 pg/mL, P=0.01, I2=99.07%; P=0.01). Subgroup analyses showed a difference in serum IL-17 levels treated by macrolide between patients and control (MD =83.96 pg/mL, 95% CI: 76.62, 91.29 pg/mL, P=0.01). In severe and mild MPP, the IL-17 levels were significantly increased (MD =19.08 pg/mL, 95% CI: 11.51, 26.65 pg/mL, P=0.01) and heterogeneity was appeared (I2=99.39%; P=0.01). For the risks of bias, two studies had a “high risk” in comparability domain, and the 7 studies were classified as “low risk” and “unclear risk”. Conclusions: Our meta-analysis revealed that serum IL-17 levels are significantly elevated in pediatric with general and severe MPP. IL-17 might be a potential biomarker or therapeutic target for pneumonia caused by M. pneumoniae.

Verified
Journal Article
Open access
PDF file
YOYu Oshima
Yu Oshima
AHAi Harashima
Ai Harashima
SMSeiichi Munesue
Seiichi Munesue
KKKumi Kimura
Kumi Kimura
NLNontaphat Leerach
Nontaphat Leerach
Yasuhiko YamamotoYasuhiko Yamamoto
Yasuhiko Yamamoto
Non-enzymatic glycation is an unavoidable reaction that occurs across biological taxa. The final products of this irreversible reaction are called advanced glycation end-products (AGEs). The endogenously formed AGEs are known to be bioactive and detrimental to human health. Additionally, exogenous food-derived AGEs are debated to contribute to the development of aging and various diseases. Receptor for AGEs (RAGE) is widely known to elicit biological reactions. The binding of RAGE to other ligands (e.g., high mobility group box 1, S100 proteins, lipopolysaccharides, and amyloid-β) can result in pathological processes via the activation of intracellular RAGE signaling pathways, including inflammation, diabetes, aging, cancer growth, and metastasis. RAGE is now recognized as a pattern-recognition receptor. All mammals have RAGE homologs; however, other vertebrates, such as birds, amphibians, fish, and reptiles, do not have RAGE at the genomic level. This evidence from an evolutionary perspective allows us to understand why mammals require RAGE. In this review, we provide an overview of the scientific knowledge about the role of RAGE in physiological and pathological processes. In particular, we focus on (1) RAGE biology, (2) the role of RAGE in physiological and pathophysiological processes, (3) RAGE isoforms, including full-length membrane-bound RAGE (mRAGE), and the soluble forms of RAGE (sRAGE), which comprise endogenous secretory RAGE (esRAGE) and an ectodomain-shed form of RAGE, and (4) oxytocin transporters in the brain and intestine, which are important for maternal bonding and social behaviors.

22 August 2025 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
PKPanisara Kasemteerasomboon
Panisara Kasemteerasomboon
Wiriya MahikulWiriya Mahikul
Wiriya Mahikul
NLNontaphat Leerach
Nontaphat Leerach
PSPeerapon Siripongwutikorn
Peerapon Siripongwutikorn
KKKulsumpun Krobanan
Kulsumpun Krobanan
JPJiraphan Premsuriya
Jiraphan Premsuriya
Antimicrobial resistance (AMR) is a significant global health concern. Due to its high prevalence in nosocomial infections and its increasing resistance to multiple antibiotics, Acinetobacter baumannii-calcoaceticus complex (ABC) is listed as a critical pathogen. This study aimed to determine the prevalence and antibiotic non-susceptibility trends of ABC in Thailand over two decades using national surveillance data. We analysed secondary data from the National Antimicrobial Resistance Surveillance Thailand (NARST) from 2000 to 2022, covering 529 538 ABC isolates. Linear regression was used to evaluate trends in overall ABC prevalence and antibiotic non-susceptibility rates across ward types (ICU, inpatient, outpatient) and specimen types (sputum, blood, urine). The prevalence of ABC increased from 8% in 2000 to 14% in 2022, with inpatient wards and sputum specimens showing the highest occurrence. By 2022, the majority of tested antibiotics showed antibiotic non-susceptibility rates exceeding 70%, with increasing trends. ICU isolates had the highest non-susceptibility, followed by inpatient and outpatient settings. Although non-susceptibility rates were lower in the outpatient setting, it exhibited the steepest increasing trends. Among specimen types, urine isolates had the highest non-susceptibility, followed by sputum and blood. Carbapenem non-susceptibility increased significantly across all ward types. The increasing prevalence and high non-susceptibility of ABC in Thailand highlight a growing threat to public health. These findings underscore the urgent need for enhanced infection control, robust antibiotic stewardship, and further research into molecular epidemiology and alternative therapies.

1 January 2023 in Translational Pediatrics
Verified
Journal Article
Open access
PDF file
NLNontaphat Leerach
Nontaphat Leerach
SSSutthirat Sitthisak
Sutthirat Sitthisak
TKThawatchai Kitti
Thawatchai Kitti
NTNattawat Teerawattanapong
Nattawat Teerawattanapong
WMWiriya Mahikul
Wiriya Mahikul
KTKannipa Tasanapak
Kannipa Tasanapak
Letter to the Editor Association between Mycoplasma pneumoniae pneumonia and interleukin-17: insights and interpretative cautions from a meta-analysis Nontaphat Leerach, Sutthirat Sitthisak, Thawatchai Kitti, Nattawat Teerawattanapong, Wiriya Mahikul, Supaporn Lamlertthon, Nathorn Chaiyakunapruk, Kannipa Tasanapak

29 August 2024 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
NLNontaphat Leerach
Nontaphat Leerach
SSSuthat Saengchoowong
Suthat Saengchoowong
LYLaphatrada Yurasakpong
Laphatrada Yurasakpong
JSJirawat Samakkan
Jirawat Samakkan
RMRadis Malaisri
Radis Malaisri
JPJiraphan Premsuriya
Jiraphan Premsuriya
Antibiotic resistant bacteria are present in various environments and are concerning for public health. Antibiotic resistance genes in soil may proliferate throughout different ecosystems and be acquired by pathogens that pose health risks to humans and animals. This study investigated the antibiotic resistance of cultivable bacteria isolated from livestock-exposed and unexposed areas in a former perlite mining area in the Fa-La-Mee Mountain range, Lopburi, Thailand. Soil samples were collected in five different locations. Soil bacteria were isolated and tested for susceptibility against seven antibiotics, followed by 16S rRNA gene-based identification. A total of 56 bacterial isolates were isolated from the perlite-rich soil samples, including 34 isolates from the livestock-exposed areas and 22 isolates from the unexposed areas. Most of the isolates were resistant to cefepime (26.5% in exposed areas and 22.7% in unexposed areas) and ampicillin (23.5% in exposed areas and 22.7% in unexposed areas). 16S rRNA gene sequences revealed that most of the resistant bacteria isolated from perlite-rich soil were Bacillus spp. A multidrug-resistant isolate of Bacillus cereus resistant to ampicillin, trimethoprim/sulfamethoxazole, and cefepime was found in a livestock-unexposed area. The majority of the culturable antibiotic-resistant bacteria isolated from perlite-rich soil were cefepime-resistant Bacillus. Interestingly, the pattern of antibiotic resistance in exposed and unexposed areas was not different, which indicated that antibiotic resistance in perlite-rich soil is likely caused by other factors, such as physicochemical characteristics and/or the microbial population of the soil rather than by antibiotics used in livestock husbandry.